ArticleOxidative medicine and cellular longevity2022

DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis.

Yongwen Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.